Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 5.90 Billion | USD 14.20 Billion | 10.26% | 2023 |
The global apoptosis assays market size was worth around USD 5.90 billion in 2023 and is predicted to grow to around USD 14.20 billion by 2032 with a compound annual growth rate (CAGR) of roughly 10.26% between 2024 and 2032.
The report covers a forecast and an analysis of the apoptosis assays market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes the drivers and restraints of the apoptosis assays market along with their impact on the demand over the forecast time period. Additionally, the report includes the study of opportunities available in the apoptosis assays market on a global and regional level.
Apoptosis assays, in simple words, are programmed cell deaths that genetically control cell ablation during their normal development process. This is used to eliminate old, unnecessary, and unhealthy cells without releasing any harmful substances into the nearby areas. The morphological features of apoptotic cells include nuclear chromatin compaction, cytoplasm contraction, and membrane-bound apoptotic bodies’ production.
The rising prevalence and incidences of various infectious and chronic diseases, growing funding for research related to cancer, and rising cell-based research are likely to drive the global apoptosis assays market development. Moreover, on-going developments related to apoptosis-modulating drugs are expected to further propel the growth of the global apoptosis assays market over the forecast time period.
However, high capital investments and expensive detection technology may restrain the growth of the apoptosis assays market. Alternatively, the wide use of apoptosis and molecular targeting therapy for the treatment of cancer and other chronic disease is also likely to support the global apoptosis assays market in the future.
In order to give the users of this report a comprehensive view of the apoptosis assays market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the apoptosis assays market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the apoptosis assays market on a global and regional basis.
Report Attributes | Report Details |
---|---|
Report Name | Apoptosis Assays Market Research Report |
Market Size in 2023 | USD 5.90 Billion |
Market Forecast in 2032 | USD 14.20 Billion |
Growth Rate | CAGR of 10.26% |
Number of Pages | 215 |
Key Companies Covered | Merck KGaA, Thermo Fischer Scientific, Bio-Rad Laboratories, GE Healthcare, Geno Technology, BioTek Instruments, Biotium, Abcam, Canvax, Abnova, Creative Bioarray, Sartorius, Promega Corporation, PerkinElmer, and Danaher Corporation |
Segments Covered | By Product, By Detection Technology, By Application, By End-User and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The study provides a decisive view of the apoptosis assays market by segmenting it based on the product, detection technology, application, end-user, and region.
By product, the market includes assay kit, reagent, instruments, and microplates. The assay kit segment held the largest market share in 2018. Based on detection technology, the market is segmented into flow cytometry, fluorescence microscopy, and others. Due to the increasing adoption of cell imaging and microscopy, the flow cytometry segment contributed the largest share to the market in 2018. By application, this global market is categorized into drug discovery and development, clinical research, stem cell research, and basic research. The drug discovery and development segment held the largest market share in 2018. By end-user, the apoptosis assays market includes pharmaceutical and biotechnology companies, diagnostic labs, hospitals, and academic and research institutes.
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
North America dominated the global apoptosis assays market in 2018, due to the large number of scientific studies being conducted across the region, growing chronic and infectious diseases prevalence, increasing support of government bodies in the form of research investments, and the availability of high-quality infrastructure for R&D. Europe held the second spot in the global apoptosis assays market, due to the increasing cases of cancer, cardiovascular diseases, and degenerative disorders. The Asia Pacific apoptosis assays market is among the emerging markets for apoptosis assays due to the increasing number of research and development facilities in the region, growing investments in the infrastructural sector, and rising number of clinical trial drug studies.
The global apoptosis assays market is led by players like:
Global Apoptosis Assays Market: By Product
Global Apoptosis Assays Market: By Detection Technology
Global Apoptosis Assays Market: By Application
Global Apoptosis Assays Market: By End-User
Global Apoptosis Assays Market: By Region
FrequentlyAsked Questions
Apoptosis assays are scientific methodologies employed in laboratories to investigate and measure the quantity of apoptosis, a form of programmed cell death that is vital for a multitude of biological processes such as tissue integrity, immune response, and development. Apoptosis dysregulation has the potential to contribute to the development of various diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. By utilizing apoptosis assays, scientists are able to examine the mechanisms that govern cell death and assess the impact of experimental treatments or pharmaceuticals on the induction or inhibition of apoptosis.
The need for apoptosis assays is propelled by the rising incidence of chronic diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions. In order to develop therapeutic strategies and gain a better understanding of the mechanisms of cell death associated with these diseases, these assays are indispensable to scientific inquiry.
The global apoptosis assays market size was worth around USD 5.90 billion in 2023 and is predicted to grow to around USD 14.20 billion by 2032.
The global apoptosis assays market with a compound annual growth rate (CAGR) of roughly 10.26% between 2024 and 2032.
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Merck KGaA, Thermo Fischer Scientific, Bio-Rad Laboratories, GE Healthcare, Geno Technology, BioTek Instruments, Biotium, Abcam, Canvax, Abnova, Creative Bioarray, Sartorius, Promega Corporation, PerkinElmer, and Danaher Corporation.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed